Navigation Links
RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder
Date:5/19/2009

ian dose of RISPERDAL(R) CONSTA(R) was 25 mg.

The most common adverse reactions in clinical trials in patients with bipolar disorder were weight increase (5% in monotherapy trial) and tremor and parkinsonism (greater than or equal to 10% in adjunctive therapy).

"This is the first randomized controlled study to demonstrate the efficacy of RLAT as a maintenance therapy in patients with Bipolar Disorder," said Joseph Palumbo, M.D., Franchise Medical Leader, Psychiatry, Central Nervous System and Pain Therapeutic Area, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD). "These findings are important because the clinical course of Bipolar Disorder is often unpredictable and relapses can be very debilitating."

The study was presented and sponsored by Janssen, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc and J&JPRD.

About RISPERDAL(R) CONSTA(R) Long Acting Treatment

RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment (RLAT) is a long-acting injectable atypical antipsychotic therapy used for the treatment of schizophrenia and the maintenance treatment of Bipolar I Disorder. It was developed utilizing Alkermes' proprietary Medisorb(R) drug-delivery technology. Using this technology, risperidone is encapsulated in microspheres made of a biodegradable polymer, which are suspended in a water-based solution and administered to patients by intramuscular injection once every two weeks. RISPERDAL(R) CONSTA(R) is manufactured by Alkermes, Inc. and marketed by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. in the U.S. and Janssen-Cilag outside of the U.S.

About Janssen

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, N.J. and is the only large pharmaceutical company in the U.S. dedicated solely to mental health. It currently has prescription medications for
'/>"/>

SOURCE Janssen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
2. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
3. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
4. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
5. Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
6. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Biobanks - How to Discover Trends, ... ,Are you interested in the future of ... commercial predictions from 2015. You stay ahead for data, ... development, results, opportunities and revenue forecasts. That ... possible for biobanking and associated technology to improve ...
(Date:7/7/2015)... BioClinica®, Inc ., ein Anbieter ... heute bekannt, dass es mit MediciGroup ® , ... Erhalt von Patienten übernommen hat. Der Kauf ... und Access to Patients, LLC. Medici bietet mit ... von Patienten, die für die Nachbeobachtung verloren gegangen ...
(Date:7/7/2015)... FRANCISCO , July 7, 2015 ... reach USD 1,197.7 million by 2020, growing at an estimated ... new study by Grand View Research, Inc. Introduction of innovative ... coupled with growing awareness levels pertaining to the advantages of ... the next six years. In addition, presence of untapped growth ...
Breaking Medicine Technology:Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
(Date:7/7/2015)... NE (PRWEB) , ... July 07, 2015 , ... ... center for MRI services, is debuting their brand new website. The website’s goal ... technology and a wider selection of patient tools, including requesting appointments online. , ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for ... of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for a ... have sex with men (MSM) and transgender women, the groups at highest risk ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Quadrino Law Group ... Road, Suite 304, Melville, New York 11747. The new facility is a state ... and rail lines. , Richard Quadrino, the firm's CEO and founder, said, "We are ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time ... so Amica Insurance is sharing some safety tips. , Jean Tapley, senior wellness coordinator ... Leisure activities/sports, , Start slowly. Going from no activity to ...
Breaking Medicine News(10 mins):Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
... people don,t get enough rest , THURSDAY, June 11 (HealthDay ... can actually boost your odds for dying prematurely, while another ... getting the recommended eight hours of slumber. , All three ... Societies annual meeting, in Seattle. , The first study, from ...
... BOSTON, June 11 GlobalEquityReport.com is ... Investors who are interested in stocks on the move and in ... http://www.GlobalEquityReport.com , , Today,s ... Generex Biotechnology, Corp. (Nasdaq: GNBT ), Cell Therapeutics, Inc. ...
... Amy G. Hise, M.D., M.P.H., assistant professor at the Center ... of Medicine, is the first to discover how the body ... human fungal pathogen, Candida . As ... research may directly lead to the development of new drugs ...
... tons of food to Volunteer,s of America City Harvest. , ... Denver" food drive by arc Thrift Stores brought in fourteen ... Stores will deliver 112 tons of non-perishable food to Volunteers ... 2009 between 8:00am and noon. This enormous shipment will require ...
... and ring finger (CHFR) is a mitotic stress checkpoint ... of cancer. In gastric cancer, CHFR promoter hypermethylation has ... genetic instability is one of the hallmarks of human ... Oki from Kyushu University examined the methylation status of ...
... (those who have not given birth to children) are ... and rheumatoid arthritis (RA) an average of 5.2 years ... children), according to a new study presented today at ... Against Rheumatism in Copenhagen, Denmark. Previous studies have highlighted ...
Cached Medicine News:Health News:Lack of Good Sleep Might Be Deadly 2Health News:Lack of Good Sleep Might Be Deadly 3Health News:GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN 2Health News:Researchers at Case Western Reserve discover a new way the body fights fungal infection 2Health News:Coloradoan's Love Affair with Giving Grows! 2Health News:Diagnosis of arthritis 5 years earlier in childless women compared to those with children 2
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. For .20mm diameter holes and larger....
...
...
...
Medicine Products: